Table 1 Demographics and characteristics of pregnant women who conceived by IVF, 2018–2023.
Characteristic | Before PSM matching | After PSM matching | ||||
|---|---|---|---|---|---|---|
Contrl group (n = 1399) | FGR group (n = 30) | p-value | Contrl group (n = 60) | FGR group (n = 30) | p-value | |
Age, n (%) | 0.849 | 1.000 | ||||
< 35 years | 817 (58.40%) | 17 (56.67%) | 34 (56.67%) | 17 (56.67%) | ||
≥ 35 years | 582 (41.60%) | 13 (43.33%) | 26 (43.33%) | 13 (43.33%) | ||
Occupation, n (%) | 0.960 | 0.878 | ||||
Employeda | 833 (59.54%) | 18 (60.00%) | 37 (61.67%) | 18 (60.00%) | ||
Otherb | 566 (40.46%) | 12 (40.00%) | 23 (38.33%) | 12 (40.00%) | ||
Ethnicity, n (%) | 0.108 | 1.000 | ||||
Han | 1,368 (97.78%) | 28 (93.33%) | 56 (93.33%) | 28 (93.33%) | ||
Otherc | 31 (2.22%) | 2 (6.67%) | 4 (6.67%) | 2 (6.67%) | ||
Pregnancy type, n (%) | 0.352 | 1.000 | ||||
Nonprimiparous | 995 (71.12%) | 19 (63.33%) | 38 (63.33%) | 19 (63.33%) | ||
Primiparous | 404 (28.88%) | 11 (36.67%) | 22 (36.67%) | 11 (36.67%) | ||
Embryo Type, n (%) | 0.789 | 1.000 | ||||
Cleavage-stage embryo | 947 (67.69%) | 21 (70.00%) | 42 (70.00%) | 21 (70.00%) | ||
Blastocyst | 452 (32.31%) | 9 (30.00%) | 18 (30.00%) | 9 (30.00%) | ||
Anemic, n (%) | 0.131 | 1.000 | ||||
No | 786 (56.18%) | 21 (70.00%) | 42 (70.00%) | 21 (70.00%) | ||
Yes | 613 (43.82%) | 9 (30.00%) | 18 (30.00%) | 9 (30.00%) | ||
Blood type, n (%) | 0.519 | 0.714 | ||||
Type A | 404 (28.88%) | 6 (20.00%) | 19 (31.67%) | 6 (20.00%) | ||
Type B | 347 (24.80%) | 6 (20.00%) | 10 (16.67%) | 6 (20.00%) | ||
Type O | 543 (38.81%) | 15 (50.00%) | 26 (43.33%) | 15 (50.00%) | ||
Type AB | 105 (7.51%) | 3 (10.00%) | 5 (8.33%) | 3 (10.00%) | ||
Infant gender, n (%) | 0.218 | 1.000 | ||||
Male | 810 (57.90%) | 14 (46.67%) | 28 (46.67%) | 14 (46.67%) | ||
Female | 589 (42.10%) | 16 (53.33%) | 32 (53.33%) | 16 (53.33%) | ||
Eclampsia, n (%) | < 0.001 | 0.001 | ||||
No | 1,305 (93.28%) | 20 (66.67%) | 56 (93.33%) | 20 (66.67%) | ||
Yes | 94 (6.72%) | 10 (33.33%) | 4 (6.67%) | 10 (33.33%) | ||
Uterine scar, n (%) | 0.596 | 0.488 | ||||
No | 1,170 (83.63%) | 24 (80.00%) | 44 (73.33%) | 24 (80.00%) | ||
Yes | 229 (16.37%) | 6 (20.00%) | 16 (26.67%) | 6 (20.00%) | ||
Gestational diabetes mellitus, n (%) | 0.033 | 0.143 | ||||
No | 1,073 (76.70%) | 18 (60.00%) | 45 (75.00%) | 18 (60.00%) | ||
Yes | 326 (23.30%) | 12 (40.00%) | 15 (25.00%) | 12 (40.00%) | ||
Hypertension in pregnancy, n (%) | < 0.001 | 0.067 | ||||
No | 1,354 (96.78%) | 25 (83.33%) | 57 (95.00%) | 25 (83.33%) | ||
Yes | 45 (3.22%) | 5 (16.67%) | 3 (5.00%) | 5 (16.67%) | ||
Thyroid disease in pregnancy, n (%) | 0.265 | 0.469 | ||||
No | 1,356 (96.93%) | 28 (93.33%) | 58 (96.67%) | 28 (93.33%) | ||
Yes | 43 (3.07%) | 2 (6.67%) | 2 (3.33%) | 2 (6.67%) | ||
Air pollution, mean (SD) | ||||||
PM2.5, µg/m3 | 25.35 (3.65) | 26.05 (3.85) | 0.287 | 25.93 (3.65) | 26.05 (3.85) | 0.871 |
PM10, µg/m3 | 45.86 (5.69) | 45.96 (5.96) | 0.943 | 45.90 (5.26) | 45.96 (5.96) | 0.963 |
NO2, µg/m3 | 36.27 (5.09) | 37.82 (5.02) | 0.108 | 37.13 (5.00) | 37.83 (5.02) | 0.638 |
O3, µg/m3 | 55.99 (6.77) | 50.60 (7.52) | < 0.001 | 54.60 (6.15) | 50.60 (7.52) | 0.008 |
SO2, µg/m3 | 6.68 (0.81) | 6.57 (0.75) | 0.458 | 6.86 (1.01) | 6.57 (0.75) | 0.281 |